in prior asbestos workers using low dose
play

in Prior Asbestos Workers using Low-Dose Computed Tomography - PowerPoint PPT Presentation

Early Diagnosis of Mesothelioma and Lung Cancer in Prior Asbestos Workers using Low-Dose Computed Tomography Cross-sectional views through the chest nodule pleural plaques pleural plaques: reliable marker for asbestos exposure


  1. Early Diagnosis of Mesothelioma and Lung Cancer in Prior Asbestos Workers using Low-Dose Computed Tomography Cross-sectional views through the chest

  2. nodule

  3. pleural plaques pleural plaques: • reliable marker for asbestos exposure • indicator of increased risk for malignant mesothelioma

  4. pleural plaques on CT

  5. thickness area / volume shape (flat or lobulated) density calcifications? involved pleura (costal, diaphragmatic, mediastinal) symmetry? fluid?

  6. malignant mesothelioma

  7. Follow up flow chart Baseline low-dose CT indeterminate nodules suspicious nodules ( ≥5 mm solid or ≥8 mm non -solid) (≥15 mm) no or inconspicuous plaques endobronchial or or nodules or mass-like plaques suspicious plaques no or non-specific nodules with effusion lobulated, asymmetric, effusion 6 months f/u immediate biopsy annual repeat 3 months f/u resolved stable growth no change no change (mucous) annual repeat bronchoscopy bi-annual repeat annual repeat biopsy etc.

  8. How do I qualify for the study? To qualify you must be: • 30 years of age or older • asbestos exposure at least 20 years ago and/or documented pleural plaques • be in general good health • no prior cancers (except non-melanotic skin cancer)

  9. asbestos CT screening at PMH • Study started March 2005 • 1287 enrolled • 13 lung cancers found • 8 pleural mesothelioma found • 4 peritoneal mesothelioma found

  10. Distribution of 64 Malignancy in 1287 participates Lung Car 20% Pleural 13% 1 Throat cancer 1 Duodenal 1 Breast Peritoneal Other 1 Liver cancer 6% malignancy 3 Pancreas cancer 61% 4 Bladder cancer 7 Esophageal cancer 3 Hemopathy 7 Kidney 3 Prostate cancer 6 Colon cancer Other Malignant 39

Recommend


More recommend